MetLife Investment Management, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$93,288
-55.5%
44,0040.0%0.00%
-50.0%
Q2 2023$209,459
-16.5%
44,0040.0%0.00%0.0%
Q1 2023$250,823
-43.5%
44,0040.0%0.00%
-50.0%
Q4 2022$444,000
-55.0%
44,0040.0%0.00%
-50.0%
Q3 2022$986,130
-9.6%
44,0040.0%0.01%
-11.1%
Q2 2022$1,090,419
-36.1%
44,0040.0%0.01%
-18.2%
Q1 2022$1,706,035
+2.8%
44,004
+55.1%
0.01%
-21.4%
Q4 2021$1,659,695
-1.3%
28,3660.0%0.01%
-12.5%
Q3 2021$1,681,253
-31.7%
28,3660.0%0.02%
-30.4%
Q2 2021$2,461,885
+5.3%
28,3660.0%0.02%
+4.5%
Q1 2021$2,338,777
-10.0%
28,366
-0.7%
0.02%
-15.4%
Q4 2020$2,598,416
+114.8%
28,576
-5.6%
0.03%
+100.0%
Q3 2020$1,209,452
+31.0%
30,259
+12.4%
0.01%
+18.2%
Q2 2020$923,454
+54.5%
26,9150.0%0.01%
+37.5%
Q1 2020$597,782
+13.5%
26,9150.0%0.01%
+60.0%
Q4 2019$526,727
+45.8%
26,915
+15.7%
0.01%
+25.0%
Q3 2019$361,228
-36.2%
23,260
-16.6%
0.00%
-33.3%
Q2 2019$566,025
+15.5%
27,8830.0%0.01%0.0%
Q1 2019$489,904
+36.9%
27,8830.0%0.01%
+50.0%
Q4 2018$357,739
-4.8%
27,883
+20.8%
0.00%0.0%
Q3 2018$375,941
+43.5%
23,0780.0%0.00%
+33.3%
Q2 2018$262,000
+16.4%
23,0780.0%0.00%0.0%
Q1 2018$225,00023,0780.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders